PolyModels Hub develops ModelFlow, a digital platform designed to modernize how biopharmaceutical companies design, refine, and scale the processes that turn molecules into approved medicines. It integrates scientific data, AI and physics-based models, and enterprise workflows to help R&D and manufacturing teams design, simulate, and optimize drug processes more efficiently than traditional laboratory-first approaches. The platform aims to reduce experimental workloads, accelerate decision-making, and improve reproducibility across the drug development lifecycle.